Clinical trial

ARNI Versus plAcebo in Patients With Congenital sYStemic Right Ventricle Heart Failure

NCT05117736

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2022-03-15

PhaseNA

Study timeline

Study start (actual)2022-03-15Date precision: day

Registry last updated2024-03-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Systemic Right Ventricleunresolved

Heart Failureunresolved

Interventions

Sacubitril / Valsartan Oral TabletDRUG · verified · RxNorm: sacubitril / valsartan Oral Tablet

PlaceboDRUG

Sponsors & collaborators

Montreal Heart Institutelead sponsor

Novartis Pharmaceuticalscollaborator

Mapped research locations

MontrealQuebec, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05117736 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.